Skip to main content
PMC home page
Genetics logoLink to Genetics
. 1976 Jul;83(3):537–550.

Inducible Monooxygenase Activities and 3-Methylcholanthrene-Initiated Tumorigenesis in Mouse Recombinant Inbred Sublines

Steven A Atlas 1,2, Benjamin A Taylor 1,2, Bhalchandra A Diwan 1,2, Daniel W Nebert 1,2
PMCID: PMC1213531  PMID: 955403

Abstract

The induction of a certain group of hepatic monooxygenase activities by polycyclic aromatic compounds is regulated by the same locus or gene cluster controlling the formation of cytochrome P1–450 (P–448) in mice. Certain inbred strains of mice are "responsive" (Ahb) to such induction, whereas others are "nonresponsive" (Ahd). A pair of closely related sublines that differ with respect to the Ah locus (for aromatic hydrocarbon responsiveness) were used to identify or confirm the pleiotropic effects of this gene. The lines were derived by sibling-mating without selection from (C57L/J x AKR/J)F 2 mice; the two sublines were separated at the F12 generation. Ten microsomal monooxygenase activities and one cytosol enzyme activity known to be associated with the Ah locus were similarly associated with cytochrome P1–450 formation in these recombinant inbred sublines as well. Nine additional hepatic monooxygenase activities studied were found not to be associated with the Ah locus; certain of these activities were increased slightly, following treatment of nonresponsive as well as responsive mice with polycyclic aromatic compounds. The Ahb-containing subline was highly susceptible to 3-methylcholanthrene-induced subcutaneous sarcomas, whereas the Ah-d-containing subline was relatively resistant. These results emphasize the potential importance of this particular enzyme for the study of coordinated regulation in mammals.

Full Text

The Full Text of this article is available as a PDF (934.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alvares A. P., Siekevitz P. Gel electrophoresis of partially purified cytochromes P450 from liver microsomes of variously-treated rats. Biochem Biophys Res Commun. 1973 Oct 1;54(3):923–929. doi: 10.1016/0006-291x(73)90782-1. [DOI] [PubMed] [Google Scholar]
  2. Conney A. H. Pharmacological implications of microsomal enzyme induction. Pharmacol Rev. 1967 Sep;19(3):317–366. [PubMed] [Google Scholar]
  3. Kouri R. E., Ratrie H., Whitmire C. E. Evidence of a genetic relationship between susceptibility to 3-methyl-cholanthrene-induced subcutaneous tumors and inducibility of aryl hydrocarbon hydroxylase. J Natl Cancer Inst. 1973 Jul;51(1):197–200. doi: 10.1093/jnci/51.1.197. [DOI] [PubMed] [Google Scholar]
  4. Kouri R. E., Salerno R. A., Whitmire C. E. Relationships between aryl hydrocarbon hydroxylase inducibility and sensitivity to chemically induced subcutaneous sarcomas in various strains of mice. J Natl Cancer Inst. 1973 Feb;50(2):363–368. doi: 10.1093/jnci/50.2.363. [DOI] [PubMed] [Google Scholar]
  5. Nebert D. W., Gielen J. E. Aryl hydrocarbon hydroxylase induction in mammalian liver cell culture. II. Effects of actinomycin D and cycloheximide on induction processes by phenobarbital or polycyclic hydrocarbons. J Biol Chem. 1971 Sep 10;246(17):5199–5206. [PubMed] [Google Scholar]
  6. Nebert D. W., Heidema J. K., Strobel H. W., Coon M. J. Genetic expression of aryl hydrocarbon hydroxylase induction. Genetic specificity resides in the fraction containing cytochromes P448 and P450. J Biol Chem. 1973 Nov 25;248(22):7631–7636. [PubMed] [Google Scholar]
  7. Nebert D. W., Robinson J. R., Niwa A., Kumaki K., Poland A. P. Genetic expression of aryl hydrocarbon hydroxylase activity in the mouse. J Cell Physiol. 1975 Apr;85(2 Pt 2 Suppl 1):393–414. doi: 10.1002/jcp.1040850407. [DOI] [PubMed] [Google Scholar]
  8. Oesch F., Jerina D. M., Daly J. W., Rice J. M. Induction, activation and inhibition of epoxide hydrase: an anomalous prevention of chlorobenzene-induced hepatotoxicity by an inhibitor of epoxide hydrase. Chem Biol Interact. 1973 Mar;6(3):189–202. doi: 10.1016/0009-2797(73)90071-9. [DOI] [PubMed] [Google Scholar]
  9. Robinson J. R., Considine N., Nebert D. W. Genetic expression of aryl hydrocarbon hydroxylase induction. Evidence for the involvement of other genetic loci. J Biol Chem. 1974 Sep 25;249(18):5851–5859. [PubMed] [Google Scholar]
  10. Robinson J. R., Felton J. S., Levitt R. C., Thorgeirsson S. S., Nebert D. W. Relationship between "aromatic hydrocarbon responsiveness" and the survival times in mice treated with various drugs and environmental compounds. Mol Pharmacol. 1975 Nov;11(6):850–865. [PubMed] [Google Scholar]
  11. Robinson J. R., Nebert D. W. Genetic expression of aryl hydrocarbon hydroxylase induction. Presence or absence of association with zoxazolamine, diphenylhydantoin, and hexobarbital metabolism. Mol Pharmacol. 1974 May;10(3):484–493. [PubMed] [Google Scholar]
  12. Sher S. P. Drug enzyme induction and drug interactions: literature tabulation. Toxicol Appl Pharmacol. 1971 Apr;18(4):780–834. doi: 10.1016/0041-008x(71)90230-4. [DOI] [PubMed] [Google Scholar]
  13. Swank R. T., Bailey D. W. Recombinant inbred lines: value in the genetic analysis of biochemical variants. Science. 1973 Sep 28;181(4106):1249–1252. doi: 10.1126/science.181.4106.1249. [DOI] [PubMed] [Google Scholar]
  14. Taylor B. A., Meier H. Mapping the adrenal lipid depletion gene of the AKR/J mouse strain. Genet Res. 1975 Dec;26(3):307–312. doi: 10.1017/s0016672300016104. [DOI] [PubMed] [Google Scholar]
  15. Thomas P. E., Kouri R. E., Hutton J. J. The genetics of aryl hydrocarbon hydroxylase induction in mice: a single gene difference between C57BL-6J and DBA-2J. Biochem Genet. 1972 Apr;6(2):157–168. doi: 10.1007/BF00486400. [DOI] [PubMed] [Google Scholar]

Articles from Genetics are provided here courtesy of Oxford University Press

RESOURCES